Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-25-000373
Filing Date
2025-01-14
Accepted
2025-01-14 11:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27698
2 filename2.txt TEXT-EXTRACT 1198
  Complete submission text file 0000000000-25-000373.txt   40103
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filed for) CIK: 0001750149 (see all company filings)

EIN.: 263407249 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-284222
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)